{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:18:35Z","timestamp":1793161115791,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"U.S.A. National Institutes of Health","award":["R01-NS052255"],"award-info":[{"award-number":["R01-NS052255"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canada Foundation for Infrastructure"},{"name":"Louise and Alan Edwards Foundation of Montreal","id":[{"id":"https:\/\/ror.org\/021435c82","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.expneurol.2012.08.023","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T22:32:50Z","timestamp":1346106770000},"page":"225-234","source":"Crossref","is-referenced-by-count":169,"title":["Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy"],"prefix":"10.1016","volume":"238","author":[{"given":"H.","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.08.023_bb0010","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0015","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1460-9568.2011.07652.x","article-title":"Terminal arbor degeneration (TAD): a novel lesion produced by the antineoplastic agent, paclitaxel","volume":"33","author":"Bennett","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.expneurol.2011.02.019","article-title":"Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline","volume":"229","author":"Boyette-Davis","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0020","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpain.2011.04.008","article-title":"Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients","volume":"12","author":"Boyette-Davis","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0306-4522(86)90052-7","article-title":"Stimulation-associated changes in frog neuromuscular junctions. A quantitative ultrastructural comparison of rapid-frozen and chemically fixed nerve terminals","volume":"17","author":"Brewer","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","article-title":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","volume":"223","author":"Bruna","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.expneurol.2010.09.004","article-title":"Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies","volume":"226","author":"Carozzi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0050","first-page":"151","article-title":"Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy","volume":"72","author":"Cata","year":"2006","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpain.2006.09.014","article-title":"Quantitative sensory findings in patients with bortezomib-induced pain","volume":"8","author":"Cata","year":"2007","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3109\/10428194.2010.483303","article-title":"Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies","volume":"51","author":"Cavaletti","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1096\/fj.11-201541","article-title":"Controlling murine and rat chronic pain through A3 adenosine receptor activation","volume":"26","author":"Chen","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0075","article-title":"The role of aberrant mitochondrial bioenergetics in diabetic neuropathy","author":"Chowdhury","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.leukres.2009.07.022","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients","volume":"34","author":"Corso","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0085","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0022-5223(04)00985-7","article-title":"Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species","volume":"128","author":"Denlinger","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/07367228509144581","article-title":"Proliferation of primary sensory neurons in adult rat dorsal root ganglion and the kinetics of retrograde cell loss after sciatic nerve section","volume":"3","author":"Devor","year":"1985","journal-title":"Somatosens. Res."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2006.08.006","article-title":"Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain","volume":"33","author":"Dougherty","year":"2007","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0105","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1523\/JNEUROSCI.6343-11.2012","article-title":"Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain","volume":"32","author":"Doyle","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bbrc.2004.07.049","article-title":"The bortezomib-induced mitochondrial damage is mediated by accumulation of active protein kinase C-delta","volume":"321","author":"Durrant","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pain.2006.01.037","article-title":"Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction","volume":"122","author":"Flatters","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2005.12.013","article-title":"Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful neuropathy","volume":"397","author":"Flatters","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10072-010-0475-2","article-title":"Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study","volume":"32","author":"Giannoccaro","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2012.08.023_bb9010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2011.10.010","article-title":"Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy","volume":"33","author":"Gilardini","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0135","series-title":"Life in the cold","first-page":"431","article-title":"Mitochondria in the cold","author":"Gnaiger","year":"2000"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0300","series-title":"Soc. Neurosci. Abstr. 806.08","article-title":"Scavenging peroxynitrite blocks the development of paclitaxel, oxaliplatin and bortezomib-induced neuropathic pain","author":"Janes","year":"2011"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2007.11.001","article-title":"Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: Effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells","volume":"210","author":"Jin","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2010.08.015","article-title":"MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma","volume":"299","author":"Jin","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0160","doi-asserted-by":"crossref","first-page":"H1633","DOI":"10.1152\/ajpheart.00701.2003","article-title":"Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion","volume":"286","author":"Kuznetsov","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0165","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-04-3684","article-title":"Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341\/bortezomib) cytotoxicity in myeloma cell lines","volume":"65","author":"Landowski","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1529-8027.2008.00192.x","article-title":"Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity","volume":"13","author":"Lanzani","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0175","doi-asserted-by":"crossref","first-page":"33714","DOI":"10.1074\/jbc.M302559200","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells","volume":"278","author":"Ling","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0305","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","article-title":"Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1","volume":"29","author":"Loprinzi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb9005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pain.2010.10.015","article-title":"Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence","volume":"152","author":"Meyer","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/157488411798375967","article-title":"Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control","volume":"6","author":"Miranda-Massari","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0200","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/1078-0432.CCR-10-2451","article-title":"Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway","volume":"17","author":"Naumann","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3 Suppl.","key":"10.1016\/j.expneurol.2012.08.023_bb0205","first-page":"S84","article-title":"Chronic treatment-related pain in cancer survivors","volume":"152","author":"Paice","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000094376","article-title":"Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up","volume":"56","author":"Pietrangeli","year":"2006","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb9000","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mito.2004.07.004","article-title":"Oxidative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria\u2014case studies","volume":"4","author":"Puchovicz","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1007046028132","article-title":"Human quadriceps muscle mitochondria: a functional characterization","volume":"208","author":"Rasmussen","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.2006.125799","article-title":"New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle","volume":"581","author":"Stephens","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-4886(86)90161-5","article-title":"Motoneurons of the rat sciatic nerve","volume":"93","author":"Swett","year":"1986","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0014-4886(91)90087-S","article-title":"Sensory neurons of the rat sciatic nerve","volume":"114","author":"Swett","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/mcne.1999.0814","article-title":"Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury","volume":"15","author":"Tsujino","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0255","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1158\/1078-0432.CCR-11-0075","article-title":"Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis","volume":"17","author":"Unterkircher","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.pain.2007.06.001","article-title":"Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine","volume":"135","author":"Xiao","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.expneurol.2012.08.023_bb0310","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pain.2011.12.011","article-title":"Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin","volume":"153","author":"Xiao","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2009.09.006","article-title":"Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel","volume":"147","author":"Xiao","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2011.10.010","article-title":"Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy","volume":"199","author":"Xiao","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuroscience.2011.12.023","article-title":"Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel","volume":"203","author":"Xiao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.08.023_bb0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2011.08.016","article-title":"Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy","volume":"232","author":"Zheng","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.08.023_bb0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612003329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612003329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T02:00:09Z","timestamp":1542765609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612003329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0014488612003329"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.08.023","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}